1. Home
  2. Companies
  3. MEM
  4. Material Events

Memphasys (ASX:MEM) — Material Events

ASX:MEM · 36 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major 1 article Significant 29 articles Notable 6 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
29
Memphasys Accelerates Felix™ Commercialisation Amid Regulatory Wins and Cost CutsMedium
Memphasys advances Felix™ commercialisation with regulatory approvals and contracts, halves losses
27 Feb 2026 ·Half Year Report ·85
Memphasys Expands ITL Deal, Eyes EU Market with Turkey EntryMedium
Memphasys ups ITL contract to A$390K, expands territory to Turkey, first EU revenues expected
18 Sept 2025 ·Contract Update ·85
Memphasys Accelerates Felix™ Rollout with Expanded MENA Deal and Cost CutsMedium
Memphasys advances Felix™ commercialisation with expanded MENA deal, cost cuts, and regulatory progress
31 Oct 2025 ·Quarterly Activities Report and Appendix 4C ·85
Memphasys Hits $102K Revenue Milestone After CE Mark ApprovalHigh
Memphasys secures CE Mark, first revenues, and multi-year contracts as it transitions to global commercial rollout
22 Jan 2026 ·Quarterly Activities Report and Appendix 4C ·85
Memphasys Raises $0.84m, Slashes Costs 40% to Boost Felix™ RolloutMedium
Memphasys raises $0.84m, cuts costs 40%, accelerates Felix™ commercialisation and manufacturing scale-up
22 Sept 2025 ·Capital Raising ·85
Memphasys Accelerates Growth with Direct Sales and IVF InnovationMedium
Memphasys shifts to direct sales, advances Felix IVF product, targets global market growth
8 Aug 2025 ·Investor Presentation ·85
Memphasys Secures Exclusive $325K Middle East Deal to Boost Felix™ GrowthHigh
Memphasys Secures Exclusive Middle East Distribution Deal with A$325K Initial Order for Felix™
8 Sept 2025 ·Commercial Partnership Agreement ·85
Memphasys Advances Felix™ System Commercial Launch with Key Regulatory SubmissionsMedium
Memphasys lodges regulatory submissions for Felix™ System in Australia and India, advances UK market entry
3 Feb 2026 ·Regulatory Update ·85
Memphasys Advances Global Commercial Scale-Up with Recurring Revenue GrowthMedium
Memphasys updates investors on global commercial scale-up and recurring revenue growth
7 Apr 2026 ·Investor Presentation and Webinar Announcement ·85
Memphasys Secures €525K Deal to Enter Italian IVF MarketMedium
Memphasys Signs Five-Year European Supply Deal with Italian IVF Group CFA Italia Worth A$925K
22 Dec 2025 ·ASX Release ·85
Memphasys Secures 1,000 Felix™ Cartridge Order from ITL, Expands MENA Market ReachMedium
Memphasys Secures 1,000 Felix™ Cartridge Order from ITL, Expands MENA Market Reach
27 May 2026 ·Sales Order Announcement ·85
Memphasys Secures Largest Felix™ Supply Deal with Monash IVFMedium
Memphasys signs exclusive 12-month supply deal with Monash IVF for Felix™ system
16 June 2026 ·Commercial Agreement ·85
Memphasys Secures Key Indian Supply Deal to Boost IVF Market GrowthMedium
Memphasys Secures Indian Supply Deal Under New Go-Direct Strategy, Targeting Rapid IVF Market Growth
28 Oct 2025 ·ASX Release ·85
Memphasys Hits Record Quarterly Revenue with Multi-Year Contracts Across Europe and MENAHigh
Memphasys achieves record quarterly revenue, secures multi-year contracts, and advances global commercialisation of Felix™ System
17 Apr 2026 ·Quarterly Report ·85
Memphasys Accelerates Australian Launch with Early TGA Approval for Felix™ SystemHigh
Memphasys Gains Early TGA Approval for Felix™ System, Accelerating Australian Commercial Launch
9 Feb 2026 ·Regulatory Approval ·Unexpected ·85
Qatar’s Largest IVF Provider Drives Surge in Felix™ Cartridge OrdersMedium
Memphasys Secures Major Repeat Orders for Felix™ System from Qatar’s Largest IVF Provider, Expands MENA Market Presence
2 Feb 2026 ·ASX Release ·85
Memphasys Accelerates Felix IVF Tech with Middle East Deal and Capital RaiseMedium
Memphasys accelerates Felix IVF tech commercialisation with new Middle East deal and capital raise
25 Sept 2025 ·Investor Presentation ·85
Memphasys Secures $530,000 Felix™ Deal to Enter Vietnam’s IVF MarketMedium
Memphasys Signs $530,000 Exclusive Felix™ Commercialisation Deal in Vietnam
1 June 2026 ·Commercial Agreement Announcement ·85
Memphasys Gains Swift UK Traction with Felix™ System Trials and Early OrdersMedium
Memphasys accelerates UK market entry with Felix™ System trials and initial orders
25 June 2026 ·Commercial Expansion Announcement ·80
Memphasys Raises $1.2M to Accelerate Felix™ Commercial RolloutMedium
Memphasys Raises $1.2M to Support Felix™ Commercial Expansion and Extends Convertible Note
18 June 2026 ·Capital Raising ·80
Memphasys Accelerates Felix™ Sales Push in Middle East Ahead of CE MarkMedium
Memphasys drives direct sales push for Felix™ in Middle East ahead of CE Mark approval
8 Dec 2025 ·ASX Release ·80
Memphasys Advances Felix™ CE Mark, Boosts Sales in Japan, Validates RoXsta™ AssayMedium
Memphasys advances Felix™ CE Mark submission, expands direct sales, validates RoXsta™, raises $1.275M
30 July 2025 ·Quarterly Activity Report and Appendix 4C ·80
Memphasys Secures A$430K Felix™ Distribution Deal in Thailand IVF MarketMedium
Memphasys secures exclusive three-year Felix™ distribution deal in Thailand worth A$430K
1 July 2026 ·Commercial Agreement ·80
Memphasys Reshapes Leadership to Accelerate Global Sales of Felix™ SystemMedium
Memphasys Restructures Leadership to Drive Global Direct-Selling Strategy for Felix™ System
10 Dec 2025 ·Leadership Restructure Announcement ·75
Memphasys Expands MENA Reach Amid Regional ChallengesMedium
Memphasys Maintains MENA Operations Amid Conflict; Secures New Orders and Expands Market Footprint
20 Mar 2026 ·ASX Release ·75
Memphasys Advances Felix System Commercialisation Amid FY25 AUD 4.94M LossMedium
Memphasys reports FY25 AUD 4.94M loss, advances Felix System commercialization and RoXsta diagnostics
29 Aug 2025 ·Appendix 4E Preliminary Final Report ·75
Memphasys’ Felix™ Scores Early 500-Cartridge Order Ahead of CE MarkMedium
Memphasys partner ITL secures early 500-cartridge Felix™ order ahead of CE Mark approval
18 Dec 2025 ·ASX Release ·Unexpected ·75
Memphasys Boosts Japan Presence with Repeat Felix™ Order from Nishitan ClinicMedium
Memphasys secures repeat Felix™ order from major Japanese fertility clinic, expands direct sales strategy
24 Oct 2025 ·ASX Release ·75
Memphasys Secures $800K to Boost Felix™ Commercial RolloutMedium
Memphasys Raises $0.8M to Accelerate Felix™ Commercial Growth
6 Feb 2026 ·Capital Raising ·75
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.